[1]Jacobs J. P., Goudarzi M., Singh N., Tong M., McHardy I. H., Ruegger P., Asadourian M., Moon B. H., Ayson A., Borneman J., McGovern D. P., Fornace A. J., Jr., Braun J.andDubinsky M. A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients[J]. Cell Mol Gastroenterol Hepatol, 2016, 2(6): 750-766.
[2]Carroll M. W., Kuenzig M. E., Mack D. R., Otley A. R., Griffiths A. M., Kaplan G. G., Bernstein C. N., Bitton A., Murthy S. K., Nguyen G. C., Lee K., Cooke-Lauder J.andBenchimol E. I. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD[J]. Journal of the Canadian Association of Gastroenterology, 2019, 2(Suppl 1): S49-S67.
[3]Kaplan G. G., Bernstein C. N., Coward S., Bitton A., Murthy S. K., Nguyen G. C., Lee K., Cooke-Lauder J.andBenchimol E. I. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology[J]. Journal of the Canadian Association of Gastroenterology, 2019, 2(Suppl 1): S6-S16.
[4]Kuenzig M. E., Lee L., El-Matary W., Weizman A. V., Benchimol E. I., Kaplan G. G., Nguyen G. C., Bernstein C. N., Bitton A., Lee K., Cooke-Lauder J.andMurthy S. K. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care[J]. Journal of the Canadian Association of Gastroenterology, 2019, 2(Suppl 1): S34-S41.
[5]Srikanth C. V.andCherayil B. J. Intestinal innate immunity and the pathogenesis of Salmonella enteritis[J]. Immunologic research, 2007, 37(1): 61-78.
[6]Peloquin J. M.andNguyen D. D. The microbiota and inflammatory bowel disease: insights from animal models[J]. Anaerobe, 2013, 24: 102-106.
[7]Plevy S., Silverberg M. S., Lockton S., Stockfisch T., Croner L., Stachelski J., Brown M., Triggs C., Chuang E., Princen F.andSingh S. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients[J]. Inflammatory bowel diseases, 2013, 19(6): 1139-1148.
[8]Rose K. L., Sherman P. M., Cooke-Lauder J., Mawani M., Benchimol E. I., Kaplan G. G., Bernstein C. N., Bitton A., Murthy S. K., Nguyen G. C.andLee K. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada[J]. Journal of the Canadian Association of Gastroenterology, 2019, 2(Suppl 1): S81-S91.
[9]Bähler C., Vavricka S. R., Schoepfer A. M., Brüngger B.andReich O. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014[J]. BMC gastroenterology, 2017, 17(1): 138-138.
[10]Yang Wenhong W. W. The diagnostic of combined detection of gut microbiota and inflammation cytokines in patients with inflammatory bowl disease[J]. Chinese Journal of Laboratory Diagnostics, 2020, 24(1): 31-34.
[11]Uzal F. A., McClane B. A., Cheung J. K., Theoret J., Garcia J. P., Moore R. J.andRood J. I. Animal models to study the pathogenesis of human and animal Clostridium perfringens infections[J]. Veterinary microbiology, 2015, 179(1-2): 23-33.
[12]Jiminez J. A., Uwiera T. C., Douglas Inglis G.andUwiera R. R. E. Animal models to study acute and chronic intestinal inflammation in mammals[J]. Gut pathogens, 2015, 7: 29-29.
[13]Jianmei1 Z., ,, Mincong1 H., ,, Yangling2 L., ,, Bo2 Z., ,andNengming1, L. Comparison on the Model Rats with Colitis Induced by 2,4,6-three Nitrobenzene Sulfonic Acid and Dex-tran Sulfate Sodium[J]. China pharmacy, 2017, 28(10): 1353-1356.
[14]HU Tingting C. H. Establishment of acute radiation proctitis model in rats[J]. Journal of Clinical Oncology, 2019, 24(7): 584-587.
[15]Kanneganti M., Mino-Kenudson M.andMizoguchi E. Animal models of colitis-associated carcinogenesis[J]. J Biomed Biotechnol, 2011, 2011: 342637.
[16]Zhang W. Construction of Antibiotic-Related Diarrhea Model[J]. Master Thesis, 2015, :
[17]Tong S. Y. C., Davis J. S., Eichenberger E., Holland T. L.andFowler V. G., Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management[J]. Clinical microbiology reviews, 2015, 28(3): 603-661.
[18]Balasubramanian D., Harper L., Shopsin B.andTorres V. J. Staphylococcus aureus pathogenesis in diverse host environments[J]. Pathogens and disease, 2017, 75(1): ftx005.
[19]Kim B. J., Park T., Moon H. C., Park S. Y., Hong D., Ko E. H., Kim J. Y., Hong J. W., Han S. W., Kim Y. G.andChoi I. S. Cytoprotective alginate/polydopamine core/shell microcapsules in microbial encapsulation[J]. Angew Chem Int Ed Engl, 2014, 53(52): 14443-14446.
[20]Dzialo M. C., Park R., Steensels J., Lievens B.andVerstrepen K. J. Physiology, ecology and industrial applications of aroma formation in yeast[J]. FEMS Microbiol Rev, 2017, 41(Supp_1): S95-s128.
[21]Horie M., Miura T., Hirakata S., Hosoyama A., Sugino S., Umeno A., Murotomi K., Yoshida Y.andKoike T. Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice[J]. Exp Anim, 2017, 66(4): 405-416.
[22]Paredes C. J., Alsaker K. V.andPapoutsakis E. T. A comparative genomic view of clostridial sporulation and physiology[J]. Nat Rev Microbiol, 2005, 3(12): 969-978.
[23]Gajdacs M., Spengler G.andUrban E. Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?[J]. Antibiotics (Basel), 2017, 6(4):
[24]Croxen M. A., Law R. J., Scholz R., Keeney K. M., Wlodarska M.andFinlay B. B. Recent advances in understanding enteric pathogenic Escherichia coli[J]. Clin Microbiol Rev, 2013, 26(4): 822-880.
[25]Golinska E., Tomusiak A., Gosiewski T., Wiecek G., Machul A., Mikolajczyk D., Bulanda M., Heczko P. B.andStrus M. Virulence factors of Enterococcus strains isolated from patients with inflammatory bowel disease[J]. World J Gastroenterol, 2013, 19(23): 3562-3572.
[26]Inglin R. C., Meile L.andStevens M. J. A. Clustering of Pan- and Core-genome of Lactobacillus provides Novel Evolutionary Insights for Differentiation[J]. BMC Genomics, 2018, 19(1): 284.
[27]Zafar H.andSaier M. H., Jr. Comparative genomics of transport proteins in seven Bacteroides species[J]. PloS one, 2018, 13(12): e0208151-e0208151.
[28]Vineis J. H., Ringus D. L., Morrison H. G., Delmont T. O., Dalal S., Raffals L. H., Antonopoulos D. A., Rubin D. T., Eren A. M., Chang E. B.andSogin M. L. Patient-Specific Bacteroides Genome Variants in Pouchitis[J]. mBio, 2016, 7(6): e01713-01716.
[29]Feng S.andMcLellan S. L. Highly Specific Sewage-Derived Bacteroides Quantitative PCR Assays Target Sewage-Polluted Waters[J]. Applied and environmental microbiology, 2019, 85(6): e02696-02618.
[30]Lopez-Siles M., Duncan S. H., Garcia-Gil L. J.andMartinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics[J]. The ISME journal, 2017, 11(4): 841-852.
[31]Munukka E., Rintala A., Toivonen R., Nylund M., Yang B., Takanen A., Hänninen A., Vuopio J., Huovinen P., Jalkanen S.andPekkala S. Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice[J]. The ISME journal, 2017, 11(7): 1667-1679.
[32]Schirmer M., Franzosa E. A., Lloyd-Price J., McIver L. J., Schwager R., Poon T. W., Ananthakrishnan A. N., Andrews E., Barron G., Lake K., Prasad M., Sauk J., Stevens B., Wilson R. G., Braun J., Denson L. A., Kugathasan S., McGovern D. P. B., Vlamakis H., Xavier R. J.andHuttenhower C. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome[J]. Nature microbiology, 2018, 3(3): 337-346.
[33]Anbazhagan A. N., Priyamvada S., Alrefai W. A.andDudeja P. K. Pathophysiology of IBD associated diarrhea[J]. Tissue barriers, 2018, 6(2): e1463897-e1463897.
[34]Priyamvada S., Gomes R., Gill R. K., Saksena S., Alrefai W. A.andDudeja P. K. Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea[J]. Inflammatory bowel diseases, 2015, 21(12): 2926-2935.
[35]Leonard M., Ryan M. P., Watson A. J., Schramek H.andHealy E. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells[J]. Kidney Int, 1999, 56(4): 1366-1377.
[36]Amrani Y., Ammit A. J.andPanettieri R. A., Jr. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases[J]. Mol Pharmacol, 2001, 60(4): 646-655.
[37]Coelho-Santos V., Gonçalves J., Fontes-Ribeiro C.andSilva A. P. Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway[J]. Journal of neuroinflammation, 2012, 9: 103-103.
[38]Kanamori Y., Murakami M., Sugiyama M., Hashimoto O., Matsui T.andFunaba M. Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes[J]. The Journal of biological chemistry, 2017, 292(24): 10275-10287.
[39]Sudhakar M., Silambanan S., Chandran A. S., Prabhakaran A. A.andRamakrishnan R. C-Reactive Protein (CRP) and Leptin Receptor in Obesity: Binding of Monomeric CRP to Leptin Receptor[J]. Frontiers in immunology, 2018, 9: 1167-1167.
[40]Lee P. T., Bird S., Zou J.andMartin S. A. M. Phylogeny and expression analysis of C-reactive protein (CRP) and serum amyloid-P (SAP) like genes reveal two distinct groups in fish[J]. Fish & shellfish immunology, 2017, 65: 42-51.
[41]Søndberg E., Sinha A. K., Gerdes K.andSemsey S. CRP Interacts Specifically With Sxy to Activate Transcription in Escherichia coli[J]. Frontiers in microbiology, 2019, 10: 2053-2053.
[42]Roulis M., Bongers G., Armaka M., Salviano T., He Z., Singh A., Seidler U., Becker C., Demengeot J., Furtado G. C., Lira S. A.andKollias G. Host and microbiota interactions are critical for development of murine Crohn's-like ileitis[J]. Mucosal immunology, 2016, 9(3): 787-797.
[43]Bastaki S. M. A., Al Ahmed M. M., Al Zaabi A., Amir N.andAdeghate E. Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats[J]. BMC complementary and alternative medicine, 2016, 16: 72-72.
[44]Almohazey D., Lo Y.-H., Vossler C. V., Simmons A. J., Hsieh J. J., Bucar E. B., Schumacher M. A., Hamilton K. E., Lau K. S., Shroyer N. F.andFrey M. R. The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1[J]. Cell death and differentiation, 2017, 24(5): 855-865.